LV15503A - 2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā - Google Patents

2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā

Info

Publication number
LV15503A
LV15503A LVP-18-108A LV180108A LV15503A LV 15503 A LV15503 A LV 15503A LV 180108 A LV180108 A LV 180108A LV 15503 A LV15503 A LV 15503A
Authority
LV
Latvia
Prior art keywords
selenopheno
cancer
prevention
treatment
chromenes
Prior art date
Application number
LVP-18-108A
Other languages
English (en)
Inventor
Pavels Arsenjans
Ilona Domračeva
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-18-108A priority Critical patent/LV15503A/lv
Publication of LV15503A publication Critical patent/LV15503A/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
    • C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings

Abstract

Izgudrojums attiecas uz 2H-selenofēn[3,2-h]hromēna atvasinājumiem un tos saturošām farmakoloģiskām kompozīcijām izmantošanai vēža profilaksē un ārstēšanā.
LVP-18-108A 2018-12-12 2018-12-12 2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā LV15503A (lv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-18-108A LV15503A (lv) 2018-12-12 2018-12-12 2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-18-108A LV15503A (lv) 2018-12-12 2018-12-12 2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā

Publications (1)

Publication Number Publication Date
LV15503A true LV15503A (lv) 2020-06-20

Family

ID=65324507

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-18-108A LV15503A (lv) 2018-12-12 2018-12-12 2H-selenofēn[3,2-h]hromēni izmantošanai vēža profilaksē un ārstēšanā

Country Status (1)

Country Link
LV (1) LV15503A (lv)

Similar Documents

Publication Publication Date Title
MY197635A (en) Benzooxazole derivatives as immunomodulators
MX2022005290A (es) Compuestos heterociclicos como inmunomoduladores.
PH12020550901A1 (en) Macrocyclic compounds for treating disease
PH12018502710A1 (en) Heterocyclic compounds as immunomodulators
PH12018501084A1 (en) Heterocyclic compounds as immunomodulators
PH12018502268A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
MX2022005780A (es) Moduladores de receptores estrogenicos.
PH12017500802B1 (en) Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
SG10201907164SA (en) Rna containing composition for treatment of tumor diseases
PH12018502535A1 (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2018005019A (es) Derivado benzofurano, su metodo de preparacion, y sus usos en medicinas.
NZ752526A (en) Pyrrolobenzodiazepine conjugates
MX2022007155A (es) Derivados de cromano novedosos que tienen actividad de degradacion de receptor de estrogeno y usos de los mismos.
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
MX2018009870A (es) Inhibidores de taf1 para la terapia del cancer.
MX2017013137A (es) Derivados de cromeno como inhibidores de las fosfoinositido-3-cina sas.
AU2018380132A8 (en) Tubulin inhibitors
MX2020000135A (es) Nuevos compuestos de quinolinona.
AU2017272405A1 (en) Imidazolone compounds as human Neutrophil Elastase inhibitors
UA120083C2 (uk) АНТИМЕТАСТАТИЧНІ 2H-СЕЛЕНОФЕНО[3,2-h]ХРОМЕНИ, ЇХ СИНТЕЗ ТА СПОСОБИ ЗАСТОСУВАННЯ ЦИХ АГЕНТІВ
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
MX2018015893A (es) Compuestos anti-cancer.
EP4275759A3 (en) Quinoline derivatives as chromobox (cbx) protein inhibitors for treating cancer
WO2019036417A3 (en) Inhibition of ngly1 for the treatment of cancer
MX2019010218A (es) Derivados de pirazol como inhibidores de bromodominio.